Delivery Order SPE2DB25D3022-SPE2DB25FWCDX
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $51,243.85. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is scheduled for completion by August 21, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $2,858.49. This firm fixed-price delivery order is set to be completed by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Jardiance 25 mg tablets (90-count packaging) with a ceiling value of $86,831.47. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, represents a competitive award with no set-aside designation. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units) valued at $3,784.87. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $4,491.46. This non-set-aside award represents a competitive delivery order for pharmaceutical supplies supporting federal medical procurement needs. The contract specifies a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,446.65 delivery order on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count). This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) on August 4, 2025, for the supply of Jardiance 25 mg tablets in a 90-count package. The contract is valued at $26,975.61 with a firm fixed price structure and an ultimate completion date of August 5, 2025. This delivery order carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Jardiance 10 mg tablets (90-count) under a firm fixed-price contract with a ceiling value of $11,356.86 and ultimate completion date of September 16, 2025. This is a non-set-aside, competitively awarded delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $4,881.13 firm fixed-price delivery order from the Defense Logistics Agency on August 11, 2025, for Jardiance 25 mg tablets (90-count supply). The contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $22,670.24 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on June 12, 2025, with a completion date of June 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCDXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count) valued at $5,638.65. This competitively awarded, firm fixed-price delivery order is set to be completed by August 8, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999,999,999 global pharmaceutical supply vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor through its extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's federal contract awards demonstrate consistent capability to fulfill diverse pharmaceutical supply requirements across multiple therapeutic domains, ranging from diabetes medications to neurological treatments and pain management pharmaceuticals. As a prime contractor under the DLA's pharmaceutical prime vendor model, AmerisourceBergen supports military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare customers through flexible contracting mechanisms designed to ensure reliable access to essential medical supplies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 8/7/25 |